These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 3348469)

  • 21. Withdrawal of trihexyphenidyl.
    McInnis M; Petursson H
    Acta Psychiatr Scand; 1985 Mar; 71(3):297-303. PubMed ID: 3984771
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapy of neurologic disorders in the elderly.
    Mancall EL; Covington TR; Alonso RJ
    Hosp Pract (Off Ed); 1984 Oct; 19(10):106E, 106I, 106L passim. PubMed ID: 6434551
    [No Abstract]   [Full Text] [Related]  

  • 23. The adverse effect of benzhexol on memory in Parkinson's disease.
    Miller E; Berrios GE; Politynska B
    Acta Neurol Scand; 1987 Oct; 76(4):278-82. PubMed ID: 3687379
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antiparkinsonian drugs causing inappropriate antidiuretic hormone secretion.
    van Laar T; Lammers GJ; Roos RA; Gerritsen JJ; Meinders AE
    Mov Disord; 1998 Jan; 13(1):176-8. PubMed ID: 9452348
    [No Abstract]   [Full Text] [Related]  

  • 25. Blindness and the validity of the double-blind procedure.
    Hughes JR; Krahn D
    J Clin Psychopharmacol; 1985 Jun; 5(3):138-42. PubMed ID: 3998203
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Torsion dystonia: a double-blind, prospective trial of high-dosage trihexyphenidyl.
    Burke RE; Fahn S; Marsden CD
    Neurology; 1986 Feb; 36(2):160-4. PubMed ID: 3511401
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Double-blind comparison of amantadine and bromocriptine for ambulatory withdrawal from cocaine dependence.
    Tennant FS; Sagherian AA
    Arch Intern Med; 1987 Jan; 147(1):109-12. PubMed ID: 3541819
    [TBL] [Abstract][Full Text] [Related]  

  • 28. No difference in the effect of biperiden and amantadine on parkinsonian- and tardive dyskinesia-type involuntary movements: a double-blind crossover, placebo-controlled study in medicated chronic schizophrenic patients.
    Silver H; Geraisy N; Schwartz M
    J Clin Psychiatry; 1995 Apr; 56(4):167-70. PubMed ID: 7713856
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Trihexyphenidyl dependence.
    McInnis M; Petursson H
    Acta Psychiatr Scand; 1984 Jun; 69(6):538-42. PubMed ID: 6741602
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A controlled study comparing trihexyphenidyl hydrochloride plus levodopa with placebo plus levodopa in patients with Parkinson's disease.
    Martin WE; Loewenson RB; Resch JA; Baker AB
    Neurology; 1974 Oct; 24(10):912-9. PubMed ID: 4606107
    [No Abstract]   [Full Text] [Related]  

  • 31. Amantadine in Parkinson's disease. A double-blind, placebo-controlled, crossover study with long-term follow-up.
    Butzer JF; Silver DE; Sahs AL
    Neurology; 1975 Jul; 25(7):603-6. PubMed ID: 807867
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Four-year treatment of patients with parkinsonism using amantadine alone or with levodopa.
    Timberlake WH; Vance MA
    Ann Neurol; 1978 Feb; 3(2):119-28. PubMed ID: 350129
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Botulinum toxin versus trihexyphenidyl in cervical dystonia: a prospective, randomized, double-blind controlled trial.
    Brans JW; Lindeboom R; Snoek JW; Zwarts MJ; van Weerden TW; Brunt ER; van Hilten JJ; van der Kamp W; Prins MH; Speelman JD
    Neurology; 1996 Apr; 46(4):1066-72. PubMed ID: 8780093
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of spasmodic torticollis with amantadine: a double-blind study.
    West HH
    Neurology; 1977 Feb; 27(2):198-9. PubMed ID: 319379
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Amantadine treatment of hemispatial neglect: a double-blind, placebo-controlled study.
    Buxbaum LJ; Ferraro M; Whyte J; Gershkoff A; Coslett HB
    Am J Phys Med Rehabil; 2007 Jul; 86(7):527-37. PubMed ID: 17581287
    [TBL] [Abstract][Full Text] [Related]  

  • 36. How blind is blind? Assessment of patient and doctor medication guesses in a placebo-controlled trial of imipramine and phenelzine.
    Rabkin JG; Markowitz JS; Stewart J; McGrath P; Harrison W; Quitkin FM; Klein DF
    Psychiatry Res; 1986 Sep; 19(1):75-86. PubMed ID: 3538107
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Amantadine reduces the duration of levodopa-induced dyskinesia: a randomized, double-blind, placebo-controlled study.
    da Silva-Júnior FP; Braga-Neto P; Sueli Monte F; de Bruin VM
    Parkinsonism Relat Disord; 2005 Nov; 11(7):449-52. PubMed ID: 16154788
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Apolipoprotein E epsilon4 and anticholinergic cognitive toxicity.
    Pomara N; Sidtis J
    J Am Geriatr Soc; 2009 Nov; 57(11):2151. PubMed ID: 20121960
    [No Abstract]   [Full Text] [Related]  

  • 39. Motor-learning impairment by amantadine in healthy volunteers.
    Hadj Tahar A; Blanchet PJ; Doyon J
    Neuropsychopharmacology; 2004 Jan; 29(1):187-94. PubMed ID: 14532914
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Memory loss, confusion, and disorientation in an elderly woman taking meclizine.
    Molloy DW
    J Am Geriatr Soc; 1987 May; 35(5):454-6. PubMed ID: 3571791
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.